Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Karen Van Nuys"'
Publikováno v:
JAMA Intern Med
This cross-sectional study uses 2017 and 2018 Medicare Part D clams to compare the amount Medicare pays for common generic prescriptions in Part D with prices available to patients without insurance at Costco.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d53ecef620e13899167c529331ed916d
https://europepmc.org/articles/PMC8261681/
https://europepmc.org/articles/PMC8261681/
Autor:
Karen Van Nuys, Alice Chen
Publikováno v:
JAMA internal medicine. 181(3)
Autor:
Daniel E. Dawes, Simeon I. Taylor, Alvin C. Powers, William T. Cefalu, Alan L. Yatvin, Dana P. Goldman, Karen Van Nuys, William H. Herman, Gina Gavlak
Publikováno v:
Diabetes Care
There are more than 30 million Americans with diabetes, a disease that costs the U.S. more than $327 billion per year (1,2). Achieving glycemic control and controlling cardiovascular risk factors have been conclusively shown to reduce diabetes compli
Publikováno v:
JACC: Heart Failure. 6:401-409
Objectives The goal of this study was to illustrate the potential benefit of effective congestive heart failure (CHF) treatment in terms of improved health, greater social value, and reduced health disparities between black and white subpopulations.
Publikováno v:
JAMA Health Forum
Key Points Question How are net expenditures on insulin distributed across manufacturers, wholesalers, pharmacies, pharmacy benefit managers, and health plans in the pharmaceutical distribution system? Findings In this cross-sectional study of the di
Publikováno v:
JAMA Intern Med
This cross-sectional study uses Medicare data to examine the uptake of Inflectra and Renflexis, and investigates physician prescribing behavior in switching between biologic and biosimilar versions.
Publikováno v:
The American journal of managed care. 24(8)
We examined how a population susceptible to hepatitis C virus (HCV) moves through the HCV screening and linkage-to-care (SLTC) continuum across insurance providers (Medicare, Medicaid, commercial) and identified opportunities for increasing the numbe
Autor:
Alan L. Yatvin, Dana P. Goldman, William T. Cefalu, Simeon I. Taylor, Alvin C. Powers, Gina Gavlak, Karen Van Nuys, Daniel E. Dawes, William H. Herman
Publikováno v:
Diabetes care. 41(8)
On page 1302 of the article cited above, the wording of the following sentence was incorrect: “In contrast, net prices received by the …
Autor:
Dana P. Goldman, Jacquelyn W Chou, Ron Brookmeyer, Douglas T. Dieterich, David Dreyfus, Karen Van Nuys
Publikováno v:
Health Affairs. 34:1666-1674
Treatment of hepatitis C virus, the most common chronic viral infection in the United States, has historically suffered from challenges including serious side effects, low efficacy, and ongoing transmission and reinfection. Recent innovations have pr
Autor:
Caroline Huber, Karen Van Nuys, Ron Brookmeyer, Christian Krauth, Jona T. Stahmeyer, U. Sbarigia, Daniel Wirth
Publikováno v:
BMJ Open Gastroenterology
Background Today9s highly efficacious, low-toxicity interferon-free treatment regimens for chronic hepatitis C virus (HCV) can cure most patients with HCV in 12–24 weeks. The aim of this study was to understand how the introduction of shorter durat